PMID- 15854667 OWN - NLM STAT- MEDLINE DCOM- 20050623 LR - 20091119 IS - 0022-4804 (Print) IS - 0022-4804 (Linking) VI - 125 IP - 2 DP - 2005 May 15 TI - Expression of TGF-beta1 in smooth muscle cells regulates endothelial progenitor cells migration and differentiation. PG - 151-6 AB - OBJECTIVE: Endothelial angiogenesis in the intima of the arterial wall is one of key events in the pathogenesis of arteriosclerosis. The molecular mechanisms by which transforming growth factor beta 1 (TGFbeta1) and endothelial progenitor cells may be responsible for angiogenesis of arteriosclerosis lesions are poorly understood. MATERIALS AND METHODS: Primary culture smooth muscle cells were transfected with pMAMneoTGFbeta1. ELISA checked VEGF expression in smooth muscle cells. Human EPCs (CD34+ cells) were cultured in pMAMneoTGFbeta1 or pMAMneo transfected smooth muscle cells conditional medium. After 21 days, differentiated endothelial colonies were confirmed by immunofluorescence for von Willebrand factor (vWF) and vascular-endothelial (VE)-cadherin. The VEGFR-1 expression in differentiated endothelial colonies was detected by ELISA. Cells migration and adhesion toward pMAMneoTGFbeta1 and pMAMneo transfected smooth muscle cells were also measured in parallel flow chamber. RESULTS: Abundant TGFbeta1 stable expressed in smooth muscle cells. TGFbeta1 transfected smooth muscle cells expressed significantly higher level VEGF than pMAMneo group. As judged by positive staining for endothelial markers vWF and VE-cadherin, the combination of TGFbeta1 transfected smooth muscle cells conditional medium produced significantly more endothelial colonies (P<0.05) than did pMAMneo group. The adhesion force between endothelial progenitor cells and smooth muscle cells in TGFbeta1 group was higher than control. CONCLUSION: TGFbeta1 expressed smooth muscle cells can be helpful for increasing endothelial progenitor cells adhesion and differentiation. It may be responsible for angiogenesis of arteriosclerosis lesions and useful for blood vessel tissue engineering. FAU - Zhu, Chuhong AU - Zhu C AD - Department of Anatomy, Biomechanics Section under the Key Lab for Biomechanics & Tissue Engineering of Ministry of Education, Third Military Medical University, Chongqing, China. zhuch99@yahoo.com FAU - Ying, Dajun AU - Ying D FAU - Zhou, Dinghua AU - Zhou D FAU - Mi, Jianhong AU - Mi J FAU - Zhang, Wei AU - Zhang W FAU - Chang, Qing AU - Chang Q FAU - Li, Li AU - Li L LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Surg Res JT - The Journal of surgical research JID - 0376340 RN - 0 (Antigens, CD) RN - 0 (Cadherins) RN - 0 (TGFB1 protein, human) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (cadherin 5) RN - 0 (von Willebrand Factor) RN - EC 2.7.10.1 (Vascular Endothelial Growth Factor Receptor-1) SB - IM MH - Antigens, CD MH - Arteriosclerosis/metabolism MH - Cadherins/metabolism MH - Cell Adhesion MH - Cell Culture Techniques MH - Cell Differentiation MH - Endothelial Cells/*metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Humans MH - Muscle, Smooth, Vascular/*metabolism/physiopathology MH - Neovascularization, Pathologic/metabolism MH - Stem Cells/*metabolism MH - Transforming Growth Factor beta/*metabolism MH - Transforming Growth Factor beta1 MH - Vascular Endothelial Growth Factor A/metabolism MH - Vascular Endothelial Growth Factor Receptor-1/metabolism MH - von Willebrand Factor/metabolism EDAT- 2005/04/28 09:00 MHDA- 2005/06/24 09:00 CRDT- 2005/04/28 09:00 PHST- 2004/07/18 00:00 [received] PHST- 2004/12/09 00:00 [revised] PHST- 2004/12/11 00:00 [accepted] PHST- 2005/04/28 09:00 [pubmed] PHST- 2005/06/24 09:00 [medline] PHST- 2005/04/28 09:00 [entrez] AID - S0022-4804(04)00711-5 [pii] AID - 10.1016/j.jss.2004.12.006 [doi] PST - ppublish SO - J Surg Res. 2005 May 15;125(2):151-6. doi: 10.1016/j.jss.2004.12.006.